DAA2177 |
complement factor H increases with age |
Molecular |
hippocampus |
Human |
CFH |
166.8% Increase Gene Expression Level |
|
DAA2180 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
58.9% Increase Gene Expression Level |
|
DAA2376 |
major histocompatibility complex, class I, C increases with age |
Molecular |
hippocampus |
Human |
HLA-C |
39.8% Increase Gene Expression Level |
|
DAA2157 |
complement factor H-related 1 increases with age |
Molecular |
hippocampus |
Human |
CFHR1 |
88.0% Increase Gene Expression Level |
|
DAA2327 |
major histocompatibility complex, class I, B increases with age |
Molecular |
hippocampus |
Human |
HLA-B |
35.0% Increase Gene Expression Level |
|
DAA2179 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
41.7% Increase Gene Expression Level |
|
DAA2362 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB5 |
184.0% Increase Gene Expression Level |
|
DAA2178 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
33.1% Increase Gene Expression Level |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB6 |
150.2% Increase Gene Expression Level |
|
DAA2335 |
major histocompatibility complex, class I-related increases with age |
Molecular |
hippocampus |
Human |
MR1 |
46.6% Increase Gene Expression Level |
|
DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA2356 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPB1 |
13.2% Increase Gene Expression Level |
|
DAA2355 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPB1 |
160.5% Increase Gene Expression Level |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA722 |
Accumulation of neuromelanin in dopaminergic nigral neurons |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA1981 |
Selective increase in oxidative damage and decrease in antioxidant function during aging in the substantia nigra |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA1115 |
Growth Arrest-specific 2 Like 3 |
Molecular |
pons |
Human |
GAS2L3 |
Increase DNA Methylation |
|
DAA1111 |
Dickkopf-like 1 |
Molecular |
pons |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA1103 |
Myogenic Differentiation 1 |
Molecular |
pons |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1091 |
ATP/GTP Binding Protein-like 5 |
Molecular |
pons |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
pons |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1095 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
pons |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1083 |
Dipeptidyl-peptidase 8 |
Molecular |
pons |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA1087 |
Rhomboid Domain Containing 1 |
Molecular |
pons |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1079 |
Pipecolic Acid Oxidase |
Molecular |
pons |
Human |
PIPOX |
Increase DNA Methylation |
|